NCT05722613 is a clinical trial in Periodontitis, sponsored by University of Baghdad.

Who is sponsoring NCT05722613?

NCT05722613 is sponsored by University of Baghdad.

What condition does NCT05722613 study?

NCT05722613 studies Periodontitis.

Is NCT05722613 still recruiting?

NCT05722613 is currently status unknown. Last updated 10 February 2023.

Last reviewed 2023-02-10 · How we verify

NCT05722613

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Diagnostic Potential of the Salivary Biomarkers to Differentiate Statuses of Periodontitis

Status unknown Last updated 10 February 2023

What this trial tests

trial in Periodontitis in 120 participants. Status unknown.

Timeline

1 May 2022

Primary endpoint
1 April 2023

1 June 2023

Quick facts

Lead sponsor	University of Baghdad
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	120
Start date	1 May 2022
Primary completion	1 April 2023
Estimated completion	1 June 2023
Sites	1 location across Iraq

Conditions studied

Periodontitis — all drugs for Periodontitis →

Sponsor

University of Baghdad

Who can join

Adults 18 to 85, any sex, with Periodontitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Periodontitis is a chronic inflammatory disease characterized by both dysbiosis of oral microbiota and proinflammatory events involving both cells and mediators from innate and adaptive immunity. These events lead to chronic inflammation of periodontal soft and hard tissues sharing many features with other chronic inflammatory diseases. These events lead to chronic inflammation of periodontal soft and hard tissues sharing many features with other chronic inflammatory diseases. Chronic inflammation is driven by various mediators, of which a significant part is attributed to the interactions within cytokine networks. While proinflammatory cytokines, including interleukin (IL) -1α, IL-1β, TNF-α, IL-6, and IL-17, contribute to acute and chronic inflammation and tissue injury, a second group with antagonist effects is formed by cytokines such as IL-10

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Diagnostic Potential of Salivary Interleukin-1<i>β</i> and IL-10 for Distinguishing Periodontal Health From Periodontitis and Stable From Unstable Periodontitis: A Case-Control Study.
Raheem ZJ, Abdulbaqi HR. · · 2024 · cited 4× · PMID 39445112 · DOI 10.1155/2024/8006278

Verify or expand the search:

Other recruiting trials for Periodontitis

Currently open trials in the same condition.

NCT07463859 — Effects of Periodontal Treatment Associated With Antimicrobial Photodynamic Therapy on Halitosis in Patients With Diabet · NA · recruiting
NCT07535177 — Gas6 and Soluble MerTK in Periodontal Diseases · recruiting
NCT07491848 — Oral-Periodontal Evaluation and Assessment of Oral Fluid Biomarkers in Patients With Hepatitis B+D · recruiting
NCT07421960 — Investigation of the Relationship Between Periodontitis and Sleep Quality · recruiting
NCT07532694 — Diode Laser-Assisted Periodontal Therapy in Kidney Transplant Recipients · NA · recruiting

Other University of Baghdad trials

Trials by the same sponsor.

NCT07417839 — (Effect of Toy Nebulizer Versus Distraction Cards on Children's Fear and Parental Satisfaction During Nebulization Thera · NA · not yet recruiting
NCT07456657 — Effect of Lavender Aromatherapy Massage on Pain and Wrist Mobility in Rheumatoid Arthritis · NA · not yet recruiting
NCT07460089 — Premature Infant Oral Motor Intervention vs. Pacifier for Oral Feeding Transition in Preterm Infants · NA · not yet recruiting
NCT07350343 — The Predictability of Directly Printed Versus Thermoformed Clear Aligners · NA · enrolling by invitation
NCT07362160 — Clear Orthodontic Expander Versus Hyrax · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05722613 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Baghdad
Last refreshed: 10 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05722613.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing